Home Federal Bancorp (NASDAQ:HFBL) reported quarterly earnings of $0.52 per share. This is a 36.84 percent increase over earnings of $0.38 per share from the same period last year.
EF Hutton Initiates Coverage On Intellia Therapeutics with Buy Rating, Announces Price Target of $130
EF Hutton analyst Michael King initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and announces Price Target of $130.